Stay updated with breaking news from Pharma Analyst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
25 Mar, 2024 New wave of potential therapies to bring paradigm shift in COPD treatment, says GlobalData Share Print page ...
11 Mar, 2024 Early diagnosis continues to pose challenges for Parkinson's disease-modifying therapies, says GlobalData Share ...
Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell therapies, says GlobalData
Otsuka Pharmaceutical is poised for a strategic transition as it approaches the loss of market exclusivity of Abilify Maintena (Aripiprazole) in Europe and the US in October 2024. This significant development signals a forthcoming shift in the drug’s sales trajectory, highlighting Otsuka’s readiness to embrace ...
The development of new weight loss medicines by pharma companies Novo Nordisk and Eli Lilly have been making great progress, but obesity care needs a much greater revolution, according to a report on Thursday.Novo Nordisk and Eli Lilly have ...